choline has been researched along with Obesity in 70 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
"Among a sample of adults with overweight and obesity, greater intake of choline and lutein+zeaxanthin was associated with faster performance on a cognitive flexibility task." | 8.12 | Dietary lutein plus zeaxanthin and choline intake is interactively associated with cognitive flexibility in middle-adulthood in adults with overweight and obesity. ( Burd, NA; Dilger, RN; Edwards, CG; Erdman, JW; Holscher, HD; Khan, NA; Reeser, GE; Thompson, SV; Walk, AM, 2022) |
"Obesity is characterized by chronic low-grade inflammation, which contributes to insulin resistance." | 6.47 | Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. ( Kirchgessner, A; Lakhan, SE, 2011) |
"Choline is a semi-essential nutrient involved in lipid and one-carbon metabolism that is compromised during MAFLD progression." | 5.91 | Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes. ( Bretter, R; Caviglia, JM; Jiang, X; Johnson, CH; Kadam, I; Korsmo, HW; Reaz, A; Saxena, A, 2023) |
"Choline is an important metabolite involved in phospholipids synthesis, including serum lipids, and is the immediate precursor of betaine." | 5.91 | Dietary choline and betaine intake, cardio-metabolic risk factors and prevalence of metabolic syndrome among overweight and obese adults. ( Abbasi, MSP; Ardekani, AM; Gharebakhshi, F; Jafarzadeh, F; Manzouri, A; Nikrad, N; Tousi, AZ; Vahdat, S; Yazdani, Y, 2023) |
"Obesity has repeatedly been linked to reorganization of the gut microbiome, yet to this point obesity therapeutics have been targeted exclusively toward the human host." | 5.72 | Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms. ( Allen, FM; Anderson, JT; Armstrong, AR; Banerjee, R; Brown, AL; Brown, JM; Buffa, JA; Burrows, A; Cook, K; Ferguson, D; Finney, C; Fung, KK; Garcia-Garcia, JC; Gliniak, CM; Goudarzi, M; Gromovsky, AD; Hazen, SL; Helsley, RN; Horak, A; Keshavarzian, A; Lusis, AJ; Mak, TD; Massey, W; McMillan, A; Mehrabian, M; Neumann, C; Orabi, D; Osborn, LJ; Sangwan, N; Schugar, RC; Swanson, G; Wang, Z; Willard, B, 2022) |
" We examined associations of weight loss diet-induced changes in a gut microbiota-related metabolite trimethylamine N-oxide (TMAO), and its precursors (choline and l-carnitine), with changes in bone mineral density (BMD) considering diabetes-related factors." | 5.30 | Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial. ( Bray, GA; Chen, Y; DiDonato, JA; Heianza, Y; LeBoff, MS; Li, X; Pei, X; Qi, L; Sacks, FM; Sun, D; Zhou, T, 2019) |
"Our findings underscore the importance of changes in TMAO, choline and L-carnitine in improving insulin sensitivity during a weight-loss intervention for obese patients." | 5.30 | Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial. ( Bray, GA; DiDonato, JA; Heianza, Y; Li, X; Qi, L; Sacks, FM; Sun, D, 2019) |
" We examined associations of 6-month changes in blood metabolites (TMAO, choline, and l-carnitine) with improvements in body weight (BW), waist circumference (WC), body fat composition, fat distribution, and resting energy expenditure (REE)." | 5.27 | Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial. ( Bray, GA; Heianza, Y; Qi, L; Sacks, FM; Smith, SR; Sun, D, 2018) |
"Studies in mice have recently linked increased dietary choline consumption to increased incidence of obesity-related metabolic diseases, while several clinical trials have reported an anti-obesity effect of high dietary choline intake." | 4.31 | Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice. ( Boon, MR; Li, Z; Liu, C; Rensen, PCN; Schönke, M; Song, Z; Wang, Y, 2023) |
"Excess vitamin intake during pregnancy leads to obesogenic phenotypes, and folic acid accounts for many of these effects in male, but not in female, offspring." | 4.02 | Excess Vitamins or Imbalance of Folic Acid and Choline in the Gestational Diet Alter the Gut Microbiota and Obesogenic Effects in Wistar Rat Offspring. ( Aardema, NDJ; Bunnell, ML; Cho, CE; Hintze, KJ; Mjaaseth, UN; Norris, JC; Ward, RE, 2021) |
"Trimethylamine N-oxide (TMAO), choline and betaine serum levels have been associated with metabolic diseases including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD)." | 4.02 | Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. ( Aguilar-Salinas, C; Campos-Pérez, F; Canizales-Quinteros, S; Gómez-Pérez, F; González-González, I; Grandini-Rosales, P; Hazen, SL; Hernández-Pando, R; Huertas-Vazquez, A; Hui, ST; Larrieta-Carrasco, E; León-Mimila, P; Li, XS; López-Contreras, B; Lusis, AJ; Macías-Kauffer, L; Morán-Ramos, S; Ocampo-Medina, E; Olivares-Arevalo, M; Shih, DM; Villamil-Ramírez, H; Villarreal-Molina, T; Wang, Z, 2021) |
"Significantly inverse correlations were found between serum betaine levels and all obesity measurements in males (r ranged from -0." | 3.88 | Higher serum choline and betaine levels are associated with better body composition in male but not female population. ( Gao, X; Randell, E; Sun, G; Zhou, H, 2018) |
" Maternal nutrition is critically involved in the growth and development of the fetus, but what about the father? The aim is to investigate the effects of paternal methyl-group donor intake (methionine, folate, betaine, choline) on paternal and offspring global DNA (hydroxy)methylation, offspring IGF2 DMR DNA methylation, and birth weight." | 3.85 | The effect of paternal methyl-group donor intake on offspring DNA methylation and birth weight. ( Bekaert, B; Devlieger, R; Duca, RC; Freson, K; Ghosh, M; Godderis, L; Huybrechts, I; Koppen, G; Langie, SAS; Pauwels, S; Truijen, I, 2017) |
" Female Wistar rats fed control diet during pregnancy were assigned to four postpartum dietary groups: control, control supplemented with methyl donors (choline, betaine, folic acid, vitamin B12), HFS and HFS supplemented with methyl donors." | 3.80 | Supplementation with methyl donors during lactation to high-fat-sucrose-fed dams protects offspring against liver fat accumulation when consuming an obesogenic diet. ( Campion, J; Cordero, P; Martinez, JA; Milagro, FI, 2014) |
"Choline deficiency has been shown to induce liver fat accumulation in both rodent and human studies." | 3.80 | Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. ( Gao, YT; Li, H; Shu, XO; Xiang, YB; Yang, G; Yu, D; Zhang, X; Zheng, W, 2014) |
"Higher triglyceride and lower HDL levels statistically account for the association between BMI and myo-inositol, pointing toward a potentially critical role for dyslipidemia in the development of cerebral neurochemical alterations in obesity." | 3.79 | Dyslipidemia links obesity to early cerebral neurochemical alterations. ( Gonzales, MM; Haley, AP; Tanaka, H; Tarumi, T, 2013) |
" The present results suggest that the coupling of high levels of choline and low levels of methionine plays an important role in the development of insulin resistance and liver steatosis." | 3.77 | Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention. ( Bachmair, EM; Boekschoten, MV; Brennan, L; Coort, SL; Daniel, H; Evelo, C; Gibney, MJ; Keijer, J; Kleemann, R; McLoughlin, GA; Muller, M; Roos, Bd; Rubio-Aliaga, I; Sailer, M; van Erk, M; van Schothorst, EM, 2011) |
"To clarify the causal relationship between insulin resistance and the development of NASH, steatohepatitis was induced in obese diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) and nondiabetic control Long-Evans Tokushima Otsuka (LETO) rats by feeding them a methionine and choline-deficient (MCD) diet." | 3.74 | Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. ( Akahori, H; Kaneko, S; Kita, Y; Kurita, S; Matsuzawa, N; Misu, H; Nakanuma, Y; Ota, T; Sakurai, M; Takamura, T; Uno, M; Zen, Y, 2007) |
" In choline-deficient Fischer 344 rats, we previously showed that fatty liver was associated with elevated hepatic DAG and sustained activation of PKC." | 3.69 | Hepatic protein kinase C is not activated despite high intracellular 1,2-sn-diacylglycerol in obese Zucker rats. ( da Costa, KA; Mar, MH; Shin, OH; Zeisel, SH, 1997) |
"Metabolomic studies on obesity and type 2 diabetes mellitus have led to a number of mechanistic insights into biomarker discovery and comprehension of disease progression at metabolic levels." | 2.52 | Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. ( Abu Bakar, MH; Ali Khan, A; Cheng, KK; Sarmidi, MR; Suan, CL; Yaakob, H; Zaman Huri, H, 2015) |
"Obesity is characterized by chronic low-grade inflammation, which contributes to insulin resistance." | 2.47 | Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. ( Kirchgessner, A; Lakhan, SE, 2011) |
"Obesity is associated with adverse effects on brain health, including an increased risk of neurodegenerative diseases." | 1.91 | Change in medial frontal cerebral metabolite concentrations following bariatric surgery. ( Bottari, SA; Britton, MK; Chen, A; Cohen, RA; Friedman, J; Gunstad, J; Porges, EC; Williamson, JB; Woods, AJ, 2023) |
"Choline is a semi-essential nutrient involved in lipid and one-carbon metabolism that is compromised during MAFLD progression." | 1.91 | Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes. ( Bretter, R; Caviglia, JM; Jiang, X; Johnson, CH; Kadam, I; Korsmo, HW; Reaz, A; Saxena, A, 2023) |
"Obesity is associated with increased intestinal permeability and a diminished immune response." | 1.91 | A Physiologically Relevant Dose of 50% Egg-Phosphatidylcholine Is Sufficient in Improving Gut Permeability while Attenuating Immune Cell Dysfunction Induced by a High-Fat Diet in Male Wistar Rats. ( Azarcoya-Barrera, J; Field, CJ; Jacobs, RL; Makarowski, A; Nelson, R; Richard, C; Rusnak, T; Wollin, B, 2023) |
"Choline is an important metabolite involved in phospholipids synthesis, including serum lipids, and is the immediate precursor of betaine." | 1.91 | Dietary choline and betaine intake, cardio-metabolic risk factors and prevalence of metabolic syndrome among overweight and obese adults. ( Abbasi, MSP; Ardekani, AM; Gharebakhshi, F; Jafarzadeh, F; Manzouri, A; Nikrad, N; Tousi, AZ; Vahdat, S; Yazdani, Y, 2023) |
"Obesity has repeatedly been linked to reorganization of the gut microbiome, yet to this point obesity therapeutics have been targeted exclusively toward the human host." | 1.72 | Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms. ( Allen, FM; Anderson, JT; Armstrong, AR; Banerjee, R; Brown, AL; Brown, JM; Buffa, JA; Burrows, A; Cook, K; Ferguson, D; Finney, C; Fung, KK; Garcia-Garcia, JC; Gliniak, CM; Goudarzi, M; Gromovsky, AD; Hazen, SL; Helsley, RN; Horak, A; Keshavarzian, A; Lusis, AJ; Mak, TD; Massey, W; McMillan, A; Mehrabian, M; Neumann, C; Orabi, D; Osborn, LJ; Sangwan, N; Schugar, RC; Swanson, G; Wang, Z; Willard, B, 2022) |
"CHOLINE had lower mean daily FI and lower rates of BW accretion (P<0." | 1.72 | Dietary choline in gonadectomized kittens improved food intake and body composition but not satiety, serum lipids, or energy expenditure. ( Abood, SK; Bakovic, M; Godfrey, H; Grant, CE; Rankovic, A; Shoveller, AK; Verbrugghe, A, 2022) |
"NAFLD is typically associated with obesity and diabetes, however it also develops in lean individuals without metabolic syndrome." | 1.72 | Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice. ( Farazi, PA; Fisher, KW; Hymel, E; Vlock, E, 2022) |
"Nonalcoholic fatty liver disease affects about 24% of the world's population and may progress to nonalcoholic steatohepatitis (NASH), cirrhosis, and hepatocellular carcinoma (HCC)." | 1.72 | Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma. ( Farazi, PA; Fisher, KW; Hymel, E, 2022) |
"This pathway is down-regulated in nonalcoholic fatty liver disease." | 1.40 | GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. ( Baud, V; Billot, K; Collin de l'Hortet, A; Fauveau, V; Gilgenkrantz, H; Guidotti, JE; Helmy, N; Prip-Buus, C; Vons, C; Zerrad-Saadi, A; Ziol, M, 2014) |
"Non-alcoholic fatty liver disease (NAFLD) is the commonest form of chronic liver disease in developed countries." | 1.40 | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. ( Azuma, T; Hoshi, N; Kawano, Y; Minami, A; Nishiumi, S; Terashima, Y; Yoshida, M, 2014) |
"Childhood obesity has become a prevalent risk to health of children and teenagers." | 1.38 | Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach. ( Blachier, F; Hao, F; He, Q; Kong, X; Li, P; Ren, P; Tang, H; Wu, G; Wu, Y; Yin, Y, 2012) |
"Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world." | 1.38 | Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. ( Camporez, JP; Eisenbarth, SC; Elinav, E; Flavell, RA; Gordon, JI; Hao, L; Henao-Mejia, J; Hoffman, HM; Jin, C; Jurczak, MJ; Kau, AL; Mehal, WZ; Shulman, GI; Strowig, T; Thaiss, CA, 2012) |
"Insulin resistance, a characteristic of gestational diabetes and obesity, is correlated with the fatty acids profile of the red cell and skeletal muscle membranes." | 1.32 | Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. ( Crawford, MA; Ghebremeskel, K; Lowy, C; Min, Y; Thomas, B, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (10.00) | 18.7374 |
1990's | 1 (1.43) | 18.2507 |
2000's | 4 (5.71) | 29.6817 |
2010's | 32 (45.71) | 24.3611 |
2020's | 26 (37.14) | 2.80 |
Authors | Studies |
---|---|
Mjaaseth, UN | 1 |
Norris, JC | 1 |
Aardema, NDJ | 1 |
Bunnell, ML | 1 |
Ward, RE | 1 |
Hintze, KJ | 1 |
Cho, CE | 1 |
Chang, TY | 1 |
Wu, CH | 1 |
Chang, CY | 1 |
Lee, FJ | 1 |
Wang, BW | 1 |
Doong, JY | 1 |
Lin, YS | 1 |
Kuo, CS | 1 |
Huang, RS | 1 |
Schugar, RC | 1 |
Gliniak, CM | 1 |
Osborn, LJ | 1 |
Massey, W | 1 |
Sangwan, N | 1 |
Horak, A | 1 |
Banerjee, R | 1 |
Orabi, D | 1 |
Helsley, RN | 1 |
Brown, AL | 1 |
Burrows, A | 1 |
Finney, C | 1 |
Fung, KK | 1 |
Allen, FM | 1 |
Ferguson, D | 1 |
Gromovsky, AD | 1 |
Neumann, C | 1 |
Cook, K | 1 |
McMillan, A | 1 |
Buffa, JA | 1 |
Anderson, JT | 1 |
Mehrabian, M | 1 |
Goudarzi, M | 1 |
Willard, B | 1 |
Mak, TD | 1 |
Armstrong, AR | 1 |
Swanson, G | 1 |
Keshavarzian, A | 1 |
Garcia-Garcia, JC | 1 |
Wang, Z | 2 |
Lusis, AJ | 2 |
Hazen, SL | 2 |
Brown, JM | 1 |
Godfrey, H | 1 |
Rankovic, A | 1 |
Grant, CE | 1 |
Shoveller, AK | 1 |
Bakovic, M | 1 |
Abood, SK | 1 |
Verbrugghe, A | 1 |
Hymel, E | 3 |
Vlock, E | 1 |
Fisher, KW | 3 |
Farazi, PA | 3 |
Fu, X | 1 |
Liu, Z | 1 |
Li, R | 1 |
Yin, J | 1 |
Sun, H | 1 |
Zhu, C | 2 |
Kong, Q | 1 |
Mou, H | 1 |
Nie, S | 1 |
Bottari, SA | 1 |
Cohen, RA | 1 |
Friedman, J | 1 |
Porges, EC | 1 |
Chen, A | 1 |
Britton, MK | 1 |
Gunstad, J | 1 |
Woods, AJ | 1 |
Williamson, JB | 1 |
Rein-Fischboeck, L | 1 |
Pohl, R | 1 |
Haberl, EM | 1 |
Mages, W | 1 |
Girke, P | 1 |
Liebisch, G | 1 |
Krautbauer, S | 1 |
Buechler, C | 1 |
Liu, C | 2 |
Song, Z | 1 |
Li, Z | 1 |
Boon, MR | 1 |
Schönke, M | 1 |
Rensen, PCN | 1 |
Wang, Y | 1 |
Korsmo, HW | 2 |
Kadam, I | 1 |
Reaz, A | 1 |
Bretter, R | 2 |
Saxena, A | 4 |
Johnson, CH | 1 |
Caviglia, JM | 1 |
Jiang, X | 4 |
Abbasi, MSP | 1 |
Tousi, AZ | 1 |
Yazdani, Y | 1 |
Vahdat, S | 1 |
Gharebakhshi, F | 1 |
Nikrad, N | 1 |
Manzouri, A | 1 |
Ardekani, AM | 1 |
Jafarzadeh, F | 1 |
Rodrigues, PM | 1 |
Afonso, MB | 1 |
Simão, AL | 1 |
Islam, T | 1 |
Gaspar, MM | 1 |
O'Rourke, CJ | 1 |
Lewinska, M | 1 |
Andersen, JB | 1 |
Arretxe, E | 1 |
Alonso, C | 1 |
Santos-Laso, Á | 1 |
Izquierdo-Sanchez, L | 1 |
Jimenez-Agüero, R | 1 |
Eizaguirre, E | 1 |
Bujanda, L | 1 |
Pareja, MJ | 1 |
Prip-Buus, C | 2 |
Banales, JM | 1 |
Rodrigues, CMP | 1 |
Castro, RE | 1 |
Rusnak, T | 1 |
Azarcoya-Barrera, J | 1 |
Wollin, B | 1 |
Makarowski, A | 1 |
Nelson, R | 1 |
Field, CJ | 1 |
Jacobs, RL | 2 |
Richard, C | 1 |
Eyupoglu, ND | 1 |
Caliskan Guzelce, E | 1 |
Acikgoz, A | 1 |
Uyanik, E | 1 |
Bjørndal, B | 1 |
Berge, RK | 2 |
Svardal, A | 2 |
Yildiz, BO | 1 |
Edwards, K | 1 |
Dave, B | 1 |
Jack-Roberts, C | 3 |
Yu, H | 1 |
Salvador, M | 1 |
Dembitzer, M | 1 |
Phagoora, J | 1 |
Li, L | 2 |
Jiang, M | 1 |
Li, Y | 1 |
Su, J | 1 |
Qu, X | 1 |
Fan, L | 1 |
Peiretti, F | 1 |
Valéro, R | 1 |
Govers, R | 1 |
Sawrey-Kubicek, L | 1 |
Bardagjy, AS | 1 |
Houts, H | 1 |
Tang, X | 1 |
Sacchi, R | 1 |
Randolph, JM | 1 |
Steinberg, FM | 1 |
Zivkovic, AM | 1 |
Prabhu, GS | 1 |
K G Rao, M | 1 |
Rai, KS | 1 |
León-Mimila, P | 1 |
Villamil-Ramírez, H | 1 |
Li, XS | 1 |
Shih, DM | 1 |
Hui, ST | 1 |
Ocampo-Medina, E | 1 |
López-Contreras, B | 1 |
Morán-Ramos, S | 1 |
Olivares-Arevalo, M | 1 |
Grandini-Rosales, P | 1 |
Macías-Kauffer, L | 1 |
González-González, I | 1 |
Hernández-Pando, R | 1 |
Gómez-Pérez, F | 1 |
Campos-Pérez, F | 1 |
Aguilar-Salinas, C | 1 |
Larrieta-Carrasco, E | 1 |
Villarreal-Molina, T | 1 |
Huertas-Vazquez, A | 1 |
Canizales-Quinteros, S | 1 |
Suchacki, KJ | 1 |
Morton, NM | 1 |
Vary, C | 1 |
Huesa, C | 1 |
Yadav, MC | 1 |
Thomas, BJ | 1 |
Turban, S | 1 |
Bunger, L | 1 |
Ball, D | 1 |
Barrios-Llerena, ME | 1 |
Guntur, AR | 1 |
Khavandgar, Z | 1 |
Cawthorn, WP | 1 |
Ferron, M | 1 |
Karsenty, G | 1 |
Murshed, M | 1 |
Rosen, CJ | 1 |
MacRae, VE | 1 |
Millán, JL | 1 |
Farquharson, C | 1 |
Edwards, CG | 1 |
Walk, AM | 1 |
Thompson, SV | 1 |
Reeser, GE | 1 |
Dilger, RN | 1 |
Erdman, JW | 1 |
Burd, NA | 1 |
Holscher, HD | 1 |
Khan, NA | 1 |
Kwee, LC | 1 |
Ilkayeva, O | 1 |
Muehlbauer, MJ | 1 |
Bihlmeyer, N | 1 |
Wolfe, B | 1 |
Purnell, JQ | 1 |
Xavier Pi-Sunyer, F | 1 |
Chen, H | 1 |
Bahnson, J | 1 |
Newgard, CB | 1 |
Shah, SH | 1 |
Laferrère, B | 1 |
Dos Santos Fechine, CPN | 1 |
Monteiro, MGCA | 1 |
Tavares, JF | 1 |
Souto, AL | 1 |
Luna, RCP | 1 |
da Silva, CSO | 1 |
da Silva, JA | 1 |
Dos Santos, SG | 1 |
de Carvalho Costa, MJ | 1 |
Persuhn, DC | 1 |
Yoo, W | 1 |
Zieba, JK | 1 |
Foegeding, NJ | 1 |
Torres, TP | 1 |
Shelton, CD | 1 |
Shealy, NG | 1 |
Byndloss, AJ | 1 |
Cevallos, SA | 1 |
Gertz, E | 1 |
Tiffany, CR | 1 |
Thomas, JD | 1 |
Litvak, Y | 1 |
Nguyen, H | 1 |
Olsan, EE | 1 |
Bennett, BJ | 1 |
Rathmell, JC | 1 |
Major, AS | 1 |
Bäumler, AJ | 1 |
Byndloss, MX | 1 |
Suzuki-Kemuriyama, N | 1 |
Abe, A | 1 |
Nakane, S | 1 |
Uno, K | 1 |
Ogawa, S | 1 |
Watanabe, A | 1 |
Sano, R | 1 |
Yuki, M | 1 |
Miyajima, K | 1 |
Nakae, D | 1 |
Joselit, Y | 1 |
Nanobashvili, K | 2 |
Malysheva, OV | 2 |
Caudill, MA | 2 |
Axen, K | 2 |
Gomaa, A | 1 |
Nam, J | 1 |
Greenwald, E | 1 |
Ajeeb, TT | 1 |
Semernina, E | 1 |
Heianza, Y | 3 |
Sun, D | 3 |
Smith, SR | 1 |
Bray, GA | 3 |
Sacks, FM | 3 |
Qi, L | 3 |
Gao, X | 1 |
Randell, E | 1 |
Zhou, H | 1 |
Sun, G | 1 |
Li, X | 3 |
DiDonato, JA | 2 |
Lees, HJ | 1 |
Swann, JR | 1 |
Poucher, S | 1 |
Holmes, E | 1 |
Wilson, ID | 1 |
Nicholson, JK | 1 |
Zhou, T | 1 |
Chen, Y | 1 |
Pei, X | 1 |
LeBoff, MS | 1 |
Haley, AP | 2 |
Gonzales, MM | 2 |
Tarumi, T | 2 |
Tanaka, H | 2 |
Xu, L | 1 |
Liu, B | 1 |
Huang, Y | 1 |
Liu, X | 1 |
Zhang, SW | 1 |
Xin, XG | 1 |
Zheng, JZ | 1 |
Linder, DE | 1 |
Freeman, LM | 1 |
Holden, SL | 1 |
Biourge, V | 1 |
German, AJ | 1 |
Jha, P | 1 |
Knopf, A | 1 |
Koefeler, H | 1 |
Mueller, M | 1 |
Lackner, C | 1 |
Hoefler, G | 1 |
Claudel, T | 1 |
Trauner, M | 1 |
Collin de l'Hortet, A | 1 |
Zerrad-Saadi, A | 1 |
Fauveau, V | 1 |
Helmy, N | 1 |
Ziol, M | 1 |
Vons, C | 1 |
Billot, K | 1 |
Baud, V | 1 |
Gilgenkrantz, H | 1 |
Guidotti, JE | 1 |
Terashima, Y | 1 |
Nishiumi, S | 1 |
Minami, A | 1 |
Kawano, Y | 1 |
Hoshi, N | 1 |
Azuma, T | 1 |
Yoshida, M | 1 |
Cordero, P | 1 |
Milagro, FI | 1 |
Campion, J | 1 |
Martinez, JA | 1 |
Yu, D | 1 |
Shu, XO | 1 |
Xiang, YB | 1 |
Li, H | 1 |
Yang, G | 1 |
Gao, YT | 1 |
Zheng, W | 1 |
Zhang, X | 1 |
Abu Bakar, MH | 1 |
Sarmidi, MR | 1 |
Cheng, KK | 1 |
Ali Khan, A | 1 |
Suan, CL | 1 |
Zaman Huri, H | 1 |
Yaakob, H | 1 |
Trøseid, M | 1 |
Hov, JR | 1 |
Nestvold, TK | 1 |
Thoresen, H | 1 |
Lappegård, KT | 1 |
Gautheron, J | 1 |
Vucur, M | 1 |
Schneider, AT | 1 |
Severi, I | 1 |
Roderburg, C | 1 |
Roy, S | 1 |
Bartneck, M | 1 |
Schrammen, P | 1 |
Diaz, MB | 1 |
Ehling, J | 1 |
Gremse, F | 1 |
Heymann, F | 1 |
Koppe, C | 1 |
Lammers, T | 1 |
Kiessling, F | 1 |
Van Best, N | 1 |
Pabst, O | 1 |
Courtois, G | 1 |
Linkermann, A | 1 |
Krautwald, S | 1 |
Neumann, UP | 1 |
Tacke, F | 1 |
Trautwein, C | 1 |
Green, DR | 1 |
Longerich, T | 1 |
Frey, N | 1 |
Luedde, M | 1 |
Bluher, M | 1 |
Herzig, S | 1 |
Heikenwalder, M | 1 |
Luedde, T | 1 |
Pauwels, S | 1 |
Truijen, I | 1 |
Ghosh, M | 1 |
Duca, RC | 1 |
Langie, SAS | 1 |
Bekaert, B | 1 |
Freson, K | 1 |
Huybrechts, I | 1 |
Koppen, G | 1 |
Devlieger, R | 1 |
Godderis, L | 1 |
Zhao, Y | 1 |
Koonen, DP | 1 |
Sletten, T | 1 |
Su, B | 1 |
Lingrell, S | 1 |
Cao, G | 1 |
Peake, DA | 1 |
Kuo, MS | 1 |
Proctor, SD | 1 |
Kennedy, BP | 1 |
Dyck, JR | 1 |
Vance, DE | 1 |
Llacuna, L | 1 |
Fernández, A | 1 |
Montfort, CV | 1 |
Matías, N | 1 |
Martínez, L | 1 |
Caballero, F | 1 |
Rimola, A | 1 |
Elena, M | 1 |
Morales, A | 1 |
Fernández-Checa, JC | 1 |
García-Ruiz, C | 1 |
Musso, G | 1 |
Gambino, R | 1 |
Cassader, M | 1 |
Rubio-Aliaga, I | 1 |
Roos, Bd | 1 |
Sailer, M | 1 |
McLoughlin, GA | 1 |
Boekschoten, MV | 1 |
van Erk, M | 1 |
Bachmair, EM | 1 |
van Schothorst, EM | 1 |
Keijer, J | 1 |
Coort, SL | 1 |
Evelo, C | 1 |
Gibney, MJ | 1 |
Daniel, H | 1 |
Muller, M | 1 |
Kleemann, R | 1 |
Brennan, L | 1 |
He, Q | 1 |
Ren, P | 1 |
Kong, X | 1 |
Wu, Y | 1 |
Wu, G | 1 |
Li, P | 1 |
Hao, F | 1 |
Tang, H | 1 |
Blachier, F | 1 |
Yin, Y | 1 |
Rinella, ME | 1 |
Siddiqui, MS | 1 |
Gardikiotes, K | 1 |
Gottstein, J | 1 |
Elias, M | 1 |
Green, RM | 1 |
Lakhan, SE | 1 |
Kirchgessner, A | 1 |
Kotas, ME | 1 |
Lee, HY | 1 |
Gillum, MP | 1 |
Annicelli, C | 1 |
Guigni, BA | 1 |
Shulman, GI | 2 |
Medzhitov, R | 1 |
Henao-Mejia, J | 1 |
Elinav, E | 1 |
Jin, C | 1 |
Hao, L | 1 |
Mehal, WZ | 1 |
Strowig, T | 1 |
Thaiss, CA | 1 |
Kau, AL | 1 |
Eisenbarth, SC | 1 |
Jurczak, MJ | 1 |
Camporez, JP | 1 |
Gordon, JI | 1 |
Hoffman, HM | 1 |
Flavell, RA | 1 |
Eagan, DE | 1 |
Vaghasia, M | 1 |
Zeisel, SH | 2 |
Xu, J | 1 |
Cai, S | 1 |
Dong, J | 1 |
Feng, J | 1 |
Chen, Z | 1 |
HECKENBACH, W | 1 |
Min, Y | 1 |
Ghebremeskel, K | 1 |
Lowy, C | 1 |
Thomas, B | 1 |
Crawford, MA | 1 |
Ota, T | 1 |
Takamura, T | 1 |
Kurita, S | 1 |
Matsuzawa, N | 1 |
Kita, Y | 1 |
Uno, M | 1 |
Akahori, H | 1 |
Misu, H | 1 |
Sakurai, M | 1 |
Zen, Y | 1 |
Nakanuma, Y | 1 |
Kaneko, S | 1 |
Yamaguchi, K | 1 |
Yang, L | 1 |
McCall, S | 1 |
Huang, J | 1 |
Yu, XX | 1 |
Pandey, SK | 1 |
Bhanot, S | 1 |
Monia, BP | 1 |
Li, YX | 1 |
Diehl, AM | 1 |
Wortham, M | 1 |
He, L | 1 |
Gyamfi, M | 1 |
Copple, BL | 1 |
Wan, YJ | 1 |
Kaminski, DL | 2 |
Mueller, EJ | 1 |
Jellinek, M | 2 |
Kutty, KM | 1 |
Shin, OH | 1 |
da Costa, KA | 1 |
Mar, MH | 1 |
Ruwart, M | 1 |
Mueller, J | 1 |
Menz, L | 1 |
Emmrich, R | 1 |
Danielsson, A | 1 |
Hochrein, M | 1 |
Schleicher, I | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus[NCT04302168] | 60 participants (Anticipated) | Interventional | 2020-04-01 | Recruiting | |||
Preventing Overweight Using Novel Dietary Strategies (Pounds Lost)[NCT00072995] | 811 participants | Interventional | 2003-09-30 | Completed | |||
Longitudinal Profiling of Gut Microbiome in Overweight or Obese Participants on a Modified Atkins Diet: a Prospective Cohort Study[NCT04207879] | 75 participants (Actual) | Observational | 2020-01-01 | Active, not recruiting | |||
The Role of Microbiome Reprogramming on Liver Fat Accumulation[NCT03914495] | 57 participants (Actual) | Interventional | 2019-05-21 | Terminated (stopped due to PI carefully considered multiple factors and decided to close study to any further enrollment.) | |||
Role of Probiotics in Treatment of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Patients by Assessing With Fibroscan[NCT04671186] | 47 participants (Actual) | Interventional | 2020-09-07 | Completed | |||
Investigation of Microbiome-based Prognostical Biomarkers in Patients With Morbid Obesity and Bariatric Surgery[NCT03391401] | 204 participants (Actual) | Observational | 2018-03-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for choline and Obesity
Article | Year |
---|---|
Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
Topics: Amino Acids; Animals; Bile Acids and Salts; Carbohydrate Metabolism; Choline; Diabetes Mellitus, Typ | 2015 |
Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Bile Acids and Salts; Carbohydrate Metabolism; | 2011 |
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Inflammatory Agents; Choline; Colitis, Ulcera | 2011 |
Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.
Topics: Animals; Betaine; Carbon; Choline; Energy Metabolism; Humans; Insulin Resistance; Metabolic Networks | 2013 |
Biological function of cholinesterase.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Butyrylcholinesterase; Choline; Cholinesterases; Clini | 1980 |
6 trials available for choline and Obesity
Article | Year |
---|---|
Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women.
Topics: Aged; Bacteria; Betaine; Choline; Cross-Over Studies; Diet; Eggs; Feces; Female; Gastrointestinal Mi | 2020 |
Metabolites and diabetes remission after weight loss.
Topics: Amino Acids, Branched-Chain; Bariatric Surgery; Betaine; Biomarkers; Choline; Diabetes Mellitus, Typ | 2021 |
Choline Metabolites, Hydroxybutyrate and HDL after Dietary Fiber Supplementation in Overweight/Obese Hypertensive Women: A Metabolomic Study.
Topics: Adult; Choline; Dietary Fiber; Dietary Supplements; Female; Humans; Hydroxybutyrates; Hypertension; | 2021 |
Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
Topics: Adipose Tissue, White; Adiposity; Adult; Body Weight; Caloric Restriction; Carnitine; Choline; Diabe | 2018 |
Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
Topics: Adipose Tissue, White; Adiposity; Adult; Body Weight; Caloric Restriction; Carnitine; Choline; Diabe | 2018 |
Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
Topics: Adipose Tissue, White; Adiposity; Adult; Body Weight; Caloric Restriction; Carnitine; Choline; Diabe | 2018 |
Changes in Gut Microbiota-Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial.
Topics: Adipose Tissue, White; Adiposity; Adult; Body Weight; Caloric Restriction; Carnitine; Choline; Diabe | 2018 |
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial.
Topics: Adult; Amino Acids; Carnitine; Choline; Diet, Reducing; Female; Gastrointestinal Microbiome; Glucose | 2019 |
Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial.
Topics: Absorptiometry, Photon; Adult; Bone Density; Carnitine; Choline; Diabetes Mellitus, Type 2; Diet, Re | 2019 |
59 other studies available for choline and Obesity
Article | Year |
---|---|
Excess Vitamins or Imbalance of Folic Acid and Choline in the Gestational Diet Alter the Gut Microbiota and Obesogenic Effects in Wistar Rat Offspring.
Topics: Animal Nutritional Physiological Phenomena; Animals; Animals, Newborn; Choline; Diet; Female; Folic | 2021 |
Optimal Dietary Intake Composition of Choline and Betaine Is Associated with Minimized Visceral Obesity-Related Hepatic Steatosis in a Case-Control Study.
Topics: Adiposity; Aged; Betaine; Biomarkers; Body Composition; Case-Control Studies; Choline; Diet Records; | 2022 |
Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms.
Topics: Animals; Choline; Circadian Rhythm; Diet, High-Fat; Enzyme Inhibitors; Gastrointestinal Microbiome; | 2022 |
Dietary choline in gonadectomized kittens improved food intake and body composition but not satiety, serum lipids, or energy expenditure.
Topics: Animals; Body Composition; Body Weight; Cats; Choline; Diet; Eating; Energy Intake; Energy Metabolis | 2022 |
Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice.
Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Choline; Diet, High-Fat; Disease Models, Animal; Di | 2022 |
Amelioration of hydrolyzed guar gum on high-fat diet-induced obesity: Integrated hepatic transcriptome and metabolome.
Topics: Animals; Anti-Obesity Agents; Biomarkers; Choline; Diet, High-Fat; Fatty Acids; Flavin-Adenine Dinuc | 2022 |
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Choline; Fructose; Liver Neoplasms; Mice; Non-alcoh | 2022 |
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Choline; Fructose; Liver Neoplasms; Mice; Non-alcoh | 2022 |
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Choline; Fructose; Liver Neoplasms; Mice; Non-alcoh | 2022 |
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cholesterol; Choline; Fructose; Liver Neoplasms; Mice; Non-alcoh | 2022 |
Change in medial frontal cerebral metabolite concentrations following bariatric surgery.
Topics: Bariatric Surgery; Choline; Creatine; Humans; Inositol; Obesity; Proton Magnetic Resonance Spectrosc | 2023 |
Lower adiposity does not protect beta-2 syntrophin null mice from hepatic steatosis and inflammation in experimental non-alcoholic steatohepatitis.
Topics: Adiposity; Animals; Cholesterol Esters; Choline; Disease Models, Animal; Fatty Acid Synthases; Fatty | 2023 |
Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice.
Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Apolipoprotein E3; Cholesterol; Cholesterol Ester Tr | 2023 |
Prenatal Choline Supplement in a Maternal Obesity Model Modulates Offspring Hepatic Lipidomes.
Topics: Animals; Choline; Diet, High-Fat; Dietary Supplements; Female; Humans; Lipidomics; Liver; Male; Mate | 2023 |
Dietary choline and betaine intake, cardio-metabolic risk factors and prevalence of metabolic syndrome among overweight and obese adults.
Topics: Adult; Betaine; Biomarkers; Cardiometabolic Risk Factors; Cholesterol; Choline; Diet; Eating; Humans | 2023 |
miR-21-5p promotes NASH-related hepatocarcinogenesis.
Topics: Animals; Carcinogenesis; Carcinoma, Hepatocellular; Choline; Liver; Liver Neoplasms; Mice; MicroRNAs | 2023 |
A Physiologically Relevant Dose of 50% Egg-Phosphatidylcholine Is Sufficient in Improving Gut Permeability while Attenuating Immune Cell Dysfunction Induced by a High-Fat Diet in Male Wistar Rats.
Topics: Animals; Choline; Cytokines; Diet, High-Fat; Interleukin-10; Interleukin-2; Lecithins; Male; Obesity | 2023 |
Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Topics: Adolescent; Adult; Betaine; Blood Glucose; Cardiovascular Diseases; Carnitine; Choline; Female; Gast | 2019 |
Prenatal Choline Supplementation during High-Fat Feeding Improves Long-Term Blood Glucose Control in Male Mouse Offspring.
Topics: Adiposity; Animals; Blood Glucose; Choline; Diet, High-Fat; Dietary Supplements; Female; Glucose Int | 2020 |
Topics: Amino Acids; Animals; Carbohydrate Metabolism; Choline; Diet, High-Fat; Diterpenes, Kaurane; Energy | 2020 |
Is ionic choline and geranate (CAGE) liquid caging diet-derived fat, limiting its absorption?
Topics: Choline; Diet; Humans; Ionic Liquids; Ions; Obesity | 2020 |
Hippocampal neural cell degeneration and memory deficit in high-fat diet-induced postnatal obese rats- exploring the comparable benefits of choline and DHA or environmental enrichment.
Topics: Animals; Animals, Newborn; Behavior, Animal; Choline; Diet, High-Fat; Disease Models, Animal; Docosa | 2021 |
Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
Topics: Adult; Betaine; Bile Acids and Salts; Biomarkers; Biopsy; Choline; Diabetes Mellitus, Type 2; Female | 2021 |
PHOSPHO1 is a skeletal regulator of insulin resistance and obesity.
Topics: Animals; Choline; Energy Metabolism; Glucose; Homeostasis; Insulin Resistance; Male; Mice; Obesity; | 2020 |
Dietary lutein plus zeaxanthin and choline intake is interactively associated with cognitive flexibility in middle-adulthood in adults with overweight and obesity.
Topics: Adult; Biomarkers; Choline; Cognition; Diet; Humans; Lutein; Middle Aged; Obesity; Overweight; Zeaxa | 2022 |
High-fat diet-induced colonocyte dysfunction escalates microbiota-derived trimethylamine
Topics: Animals; Cell Hypoxia; Choline; Colon; Diet, High-Fat; Energy Metabolism; Epithelial Cells; Escheric | 2021 |
Nonobese mice with nonalcoholic steatohepatitis fed on a choline-deficient, l-amino acid-defined, high-fat diet exhibit alterations in signaling pathways.
Topics: Amino Acids; Animals; Choline; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Lipid Met | 2021 |
Choline Supplementation Normalizes Fetal Adiposity and Reduces Lipogenic Gene Expression in a Mouse Model of Maternal Obesity.
Topics: Adiposity; Animals; Blood Glucose; Choline; Diet, High-Fat; Dietary Supplements; Disease Models, Ani | 2017 |
Choline prevents fetal overgrowth and normalizes placental fatty acid and glucose metabolism in a mouse model of maternal obesity.
Topics: Animals; Biomarkers; Choline; Diet, High-Fat; Dietary Supplements; Fatty Acid Transport Proteins; Fe | 2017 |
Higher serum choline and betaine levels are associated with better body composition in male but not female population.
Topics: Absorptiometry, Photon; Adult; Betaine; Body Composition; Body Mass Index; Body Weight; Choline; Cro | 2018 |
Obesity and Cage Environment Modulate Metabolism in the Zucker Rat: A Multiple Biological Matrix Approach to Characterizing Metabolic Phenomena.
Topics: Amino Acids, Branched-Chain; Animals; Choline; Creatine; Disease Models, Animal; Environment; Gastro | 2019 |
Dyslipidemia links obesity to early cerebral neurochemical alterations.
Topics: Adult; Aspartic Acid; Blood Glucose; Blood Pressure; Body Mass Index; Brain; Brain Diseases; Cholest | 2013 |
3.0 T proton magnetic resonance spectroscopy of the liver: quantification of choline.
Topics: Adult; Age Factors; Aged; Biomarkers; Body Mass Index; Choline; Fatty Liver; Female; Humans; Lipids; | 2013 |
Status of selected nutrients in obese dogs undergoing caloric restriction.
Topics: Amino Acids; Animals; Caloric Restriction; Choline; Creatinine; Dog Diseases; Dogs; Female; Glycine; | 2013 |
Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH).
Topics: Adipogenesis; Adipose Tissue; Animals; Choline; Disease Models, Animal; Fatty Acids; Fatty Acids, No | 2014 |
GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.
Topics: Animals; Blotting, Western; Cell Proliferation; Choline; Diet; Down-Regulation; ErbB Receptors; Fatt | 2014 |
Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis.
Topics: Animals; Choline; Diet; Fatty Liver; Liver; Liver Cirrhosis; Male; Metabolome; Methionine; Mice, Inb | 2014 |
Supplementation with methyl donors during lactation to high-fat-sucrose-fed dams protects offspring against liver fat accumulation when consuming an obesogenic diet.
Topics: Adipose Tissue; Animals; Betaine; Body Composition; Choline; Diet; Diet, High-Fat; Dietary Sucrose; | 2014 |
Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.
Topics: Adult; Aged; Animals; Asian People; Body Mass Index; Body Weight; Choline; Choline Deficiency; Dose- | 2014 |
Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Topics: Adult; Atherosclerosis; Bariatric Surgery; Betaine; Body Mass Index; Cardiovascular Diseases; Carnit | 2016 |
The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.
Topics: Adipocytes; Adipose Tissue, White; Animals; Apoptosis; Body Mass Index; Caspase 8; Choline; Choline | 2016 |
The effect of paternal methyl-group donor intake on offspring DNA methylation and birth weight.
Topics: Adult; Belgium; Betaine; Birth Weight; Choline; DNA Methylation; Female; Fetal Blood; Folic Acid; Hu | 2017 |
Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.
Topics: Animals; Betaine; Choline; Diet; Dietary Fats; Dietary Supplements; Energy Metabolism; Fatty Liver; | 2010 |
Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol, Dietary; Choline; Choline Deficiency; | 2011 |
Alterations in hepatic one-carbon metabolism and related pathways following a high-fat dietary intervention.
Topics: Animals; Blood Glucose; Carbon; Cholesterol; Choline; Dietary Fats; Fatty Liver; Hyperglycemia; Insu | 2011 |
Comparison of serum metabolite compositions between obese and lean growing pigs using an NMR-based metabonomic approach.
Topics: Animals; Blood Glucose; Body Composition; Choline; Glucagon; Insulin; Lipid Metabolism; Lipoproteins | 2012 |
Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis.
Topics: Activating Transcription Factor 6; Animal Feed; Animals; Choline; Choline Deficiency; Cytokines; Dia | 2011 |
Impact of CD1d deficiency on metabolism.
Topics: Animals; Antigens, CD1d; Body Weight; Chemokine CXCL16; Chemokine CXCL6; Choline; Diet, High-Fat; Fa | 2011 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.
Topics: Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Carrier Proteins; Choline; | 2012 |
Indirect effects of elevated body mass index on memory performance through altered cerebral metabolite concentrations.
Topics: Adult; Aspartic Acid; Biomarkers; Body Mass Index; Brain; Choline; Cognition Disorders; Creatine; Fe | 2012 |
Metabolomic profilings of urine and serum from high fat-fed rats via 1H NMR spectroscopy and pattern recognition.
Topics: 3-Hydroxybutyric Acid; Animals; Choline; Citric Acid; Creatinine; Diabetes Mellitus, Type 2; Dietary | 2013 |
[Eupond in obesity].
Topics: Atropine; Bile Acids and Salts; Choline; Cycloheptanes; Drug Combinations; Inulin; Obesity; Plants; | 1955 |
Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes.
Topics: Adult; Arachidonic Acid; Choline; Diabetes Mellitus; Diabetes, Gestational; Docosahexaenoic Acids; E | 2004 |
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Topics: Animal Feed; Animals; Choline; Collagen Type I; Collagen Type I, alpha 1 Chain; Diabetes Mellitus, T | 2007 |
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Topics: Adiponectin; Animal Feed; Animals; Blood Glucose; Choline; Cytochrome P-450 CYP2E1; Diacylglycerol O | 2007 |
The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet.
Topics: Animals; Choline; Disease Models, Animal; Disease Progression; Fatty Liver; Female; Food, Formulated | 2008 |
Effect of small intestinal bypass on hepatic lipid accumulation in rats.
Topics: Acetyl-CoA Carboxylase; Animals; Choline; Choline Deficiency; Female; In Vitro Techniques; Intestine | 1980 |
Hepatic protein kinase C is not activated despite high intracellular 1,2-sn-diacylglycerol in obese Zucker rats.
Topics: Animals; Cell Membrane; Choline; Diglycerides; Enzyme Activation; Fatty Liver; Liver; Obesity; Prote | 1997 |
Small--intestinal bypass in nutritionally obese rats receiving choline supplement.
Topics: Animals; Body Weight; Choline; Intestine, Small; Lipid Metabolism; Liver; Obesity; Rats | 1976 |
[Therapy of arteriosclerosis].
Topics: Anticholesteremic Agents; Anticoagulants; Arteriosclerosis; Cholesterol; Choline; Diabetes Complicat | 1968 |
Techniques for measuring amylase secretion from pieces of mouse pancreas.
Topics: Amylases; Animals; Carbamates; Cholecystokinin; Choline; Dinitrophenols; Epinephrine; Evaluation Stu | 1974 |
[Multicausal pathogenesis and therapy of obesity].
Topics: Choline; Cycloparaffins; Drug Combinations; Furans; Humans; Inulin; Obesity; Phenylacetates; Plants, | 1971 |